The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2022

Filed:

Mar. 18, 2019
Applicant:

China Medical University, Taichung, TW;

Inventors:

Woei-Cherng Shyu, Taichung, TW;

Chen-Huan Lin, Taichung, TW;

Wei Lee, Taipei, TW;

Chien-Lin Chen, New Taipei, TW;

Long-Bin Jeng, Taichung, TW;

Chang-Hai Tsai, Taichung, TW;

Assignee:

CHINA MEDICAL UNIVERSITY, Taichung, TW;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/28 (2015.01); A61P 35/00 (2006.01); C07K 14/705 (2006.01); C12N 5/0775 (2010.01); C12N 9/12 (2006.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61P 35/00 (2018.01); C07K 14/70521 (2013.01); C07K 14/70575 (2013.01); C12N 5/0668 (2013.01); C12N 9/1211 (2013.01); C12Y 207/01021 (2013.01);
Abstract

The present disclosure provides an engineered stem cell, comprising a vector comprising a polynucleotide comprising a nucleic acid sequence of suicide gene, a nucleic acid sequence of immune checkpoint gene and a natural cytotoxicity triggering receptor or a TNF-related apoptosis-inducing ligand, wherein the stem cell is a tumor-targeting cell. The present disclosure also provides a method for treating a cancer or enhancing intratumor immunity or enhancing immunity in tumor microenvironment in a subject, comprising administering an effective amount of the engineered stem cell of the present disclosure to the subject.


Find Patent Forward Citations

Loading…